Patient Resources

About Mass General Neurotherapeutics

Mass General Neurotherapeutics is a vibrant community of investigators and clinical researchers, developing cutting-edge, breakthrough therapies for the most challenging and devasting neurological and psychiatric disorders. We take on the greatest challenges – in close partnership with our patients and in collaboration with our many partners across Mass General and the scientific community - making discoveries and effectively translating them into therapies for patients. Our multi-disciplinary approach combines the highest level of patient care with Mass General’s world class neurotherapeutics research endeavors and facilities.

We are relentless in our mission to hasten drug discoveries to meet the needs of patients everywhere suffering from debilitating neurological and psychiatric disorders.

Below, you will find links to current clinical trials and educational material to better understand neurological and psychiatric medical issues, as well as information about our latest neurotherapeutic breakthroughs, research and clinical advances.

Related Clinical Trials

We focus on modern and emerging therapies including electroconvulsive therpay (ECT), vagus nerve stimulation (VNS) and functional neurosurgery.

Electroconvulsive Therapy (ECT) for Depression

Are you planning on receiving ECT treatments for depression? Are you interested in getting an MRI scan of your brain? If you answered yes, you may be eligible for our study.

 

Low Field Magnetic Stimulation

Investigating a novel treatment for bipolar depression in older adults aged 55 and older.

 

Neuroimaging Study of Chronic Low Back Pain

Recruiting subjects and healthy volunteers for a research study to understand the epigenetic changes in the brains of patients with chronic low back pain.

Education

• ALS Patient Education
•  
• Diagnosing ALS
• About Electromyography (EMG) Tests

• Parkinson's Disease Cell Therapy

• Transcranial Magnetic Stimulation (TMS) Clinical Service
• CAR T-Cell Therapies

• Multi-Departmental Epilepsy Initiative

Advances in Neurotherapeutics

Read our latest neurotherapeutic breakthroughs, research and clinical advances.

• Mass General Center Advances Technology for Neurorecovery

• Artificial Intelligence Identifies Adults with ADHD Using EEG Features

• Why Mass General Neurologists Are Animated About Big Data

• COVID-19 Acuity Score Identifies Outpatients at High or Low Risk of Adverse Outcomes

• Neural Network Beats Experts at Detecting Epileptiform Discharges on EEGs

• Translation, Discovery and Collaboration in Psychiatry

• AI–IPL Functional Connectivity Identified as Potential Biomarker of Bipolar Disorder

• Automated Clustering of Continuous EEG Data Accelerates Physician Review

• New, Portable Scanner to Bring MRI to the Patient 

• MRI Techniques Can Assess Neuroinflammation in Humans

• Functional MRI Detects Intact Brain Network in Patient Unresponsive After COVID-19